Functional bioinformatics: the cellular response database.

Biological Scientists function in an increasingly data rich environment. The emerging field of bioinformatics is attempting to insure that this flow of information can be structured to support the generation of significant biological hypothesis and ultimately new knowledge. To date, most of the current databases have focused on protein and nucleic acid sequence information as the principle type of data stored for further interpretation. In this paper, we describe the Cellular Response Database. This database stores functional information regarding the changes of cellular gene expression associated with various stimuli, and supports queries linking cell types, expressed genes, and inducers. The database is designed to support information-intensive queries to aid in the determination of biological function, and is flexible enough to allow the storage of a broad range of experimental data such as cytotoxicity data, immunoassays of target gene protein expression, and others.

[1]  F. Sandoval,et al.  Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha. , 1997, Immunopharmacology.

[2]  J. Marth,et al.  Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. , 1995, Journal of immunology.

[3]  J. Sorace,et al.  Identification of an endotoxin and IFN‐inducible cDNA: possible identification of a novel protein family , 1995, Journal of leukocyte biology.

[4]  J. Cohen.  The genomics gamble. , 1997, Science.

[5]  B. Zwilling,et al.  Cloning and characterization of a novel cDNA that is IFN‐γ‐induced in mouse peritoneal macrophages and encodes a putative GTP‐binding protein , 1995, Journal of leukocyte biology.

[6]  K Canfield,et al.  Information engineering for molecular diagnostics. , 1994, Proceedings. Symposium on Computer Applications in Medical Care.

[7]  G. Kaplan,et al.  Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation , 1993, The Journal of experimental medicine.

[8]  T. Molitor,et al.  Thalidomide Inhibits Tumor Necrosis Factor-α Production by Lipopolysaccharide- and Lipoarabinomannan-Stimulated Human Microglial Cells , 1995 .

[9]  G. S. Johnson,et al.  An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.

[10]  F. Sandoval,et al.  Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells. , 1996, Immunopharmacology and immunotoxicology.

[11]  Jon Cohen,et al.  Biotechnology: The Genomics Gamble , 1997, Science.

[12]  D. Largaespada,et al.  Identification of a Novel GTPase, the Inducibly Expressed GTPase, That Accumulates in Response to Interferon γ* , 1996, The Journal of Biological Chemistry.

[13]  R. Wall,et al.  The IRG-47 gene is IFN-gamma induced in B cells and encodes a protein with GTP-binding motifs. , 1992, Journal of immunology.

[14]  Richard N. Zare.  Knowledge and Distributed Intelligence , 1997, Science.

[15]  G. Kaplan,et al.  Thalidomide inhibits the replication of human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.